Literature DB >> 19028686

Cathepsin K activity-dependent regulation of osteoclast actin ring formation and bone resorption.

Susan R Wilson1, Christoph Peters, Paul Saftig, Dieter Brömme.   

Abstract

Cathepsin K is responsible for the degradation of type I collagen in osteoclast-mediated bone resorption. Collagen fragments are known to be biologically active in a number of cell types. Here, we investigate their potential to regulate osteoclast activity. Mature murine osteoclasts were seeded on type I collagen for actin ring assays or dentine discs for resorption assays. Cells were treated with cathepsins K-, L-, or MMP-1-predigested type I collagen or soluble bone fragments for 24 h. The presence of actin rings was determined fluorescently by staining for actin. We found that the percentage of osteoclasts displaying actin rings and the area of resorbed dentine decreased significantly on addition of cathepsin K-digested type I collagen or bone fragments, but not with cathepsin L or MMP-1 digests. Counterintuitively, actin ring formation was found to decrease in the presence of the cysteine proteinase inhibitor LHVS and in cathepsin K-deficient osteoclasts. However, cathepsin L deficiency or the general MMP inhibitor GM6001 had no effect on the presence of actin rings. Predigestion of the collagen matrix with cathepsin K, but not by cathepsin L or MMP-1 resulted in an increased actin ring presence in cathepsin K-deficient osteoclasts. These studies suggest that cathepsin K interaction with type I collagen is required for 1) the release of cryptic Arg-Gly-Asp motifs during the initial attachment of osteoclasts and 2) termination of resorption via the creation of autocrine signals originating from type I collagen degradation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028686      PMCID: PMC2629117          DOI: 10.1074/jbc.M805280200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  Toward a genetic analysis of cell-matrix adhesion.

Authors:  R O Hynes; E L George; E N Georges; J L Guan; H Rayburn; J T Yang
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1992

2.  Kinetics of the osteoclast cytoskeleton during the resorption cycle in vitro.

Authors:  P T Lakkakorpi; H K Väänänen
Journal:  J Bone Miner Res       Date:  1991-08       Impact factor: 6.741

Review 3.  Structural basis of substrate specificity in the serine proteases.

Authors:  J J Perona; C S Craik
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

4.  Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.

Authors:  R J Riese; P R Wolf; D Brömme; L R Natkin; J A Villadangos; H L Ploegh; H A Chapman
Journal:  Immunity       Date:  1996-04       Impact factor: 31.745

5.  Vinyl sulfones as mechanism-based cysteine protease inhibitors.

Authors:  J T Palmer; D Rasnick; J L Klaus; D Brömme
Journal:  J Med Chem       Date:  1995-08-18       Impact factor: 7.446

6.  Integrins and osteoclastic resorption in three bone organ cultures: differential sensitivity to synthetic Arg-Gly-Asp peptides during osteoclast formation.

Authors:  G van der Pluijm; H Mouthaan; C Baas; H de Groot; S Papapoulos; C Löwik
Journal:  J Bone Miner Res       Date:  1994-07       Impact factor: 6.741

7.  RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin.

Authors:  M E Flores; M Norgård; D Heinegård; F P Reinholt; G Andersson
Journal:  Exp Cell Res       Date:  1992-08       Impact factor: 3.905

8.  Effects of kistrin on bone resorption in vitro and serum calcium in vivo.

Authors:  K L King; J J D'Anza; S Bodary; R Pitti; M Siegel; R A Lazarus; M S Dennis; R G Hammonds; S C Kukreja
Journal:  J Bone Miner Res       Date:  1994-03       Impact factor: 6.741

9.  Molecular cloning of human cDNA for cathepsin K: novel cysteine proteinase predominantly expressed in bone.

Authors:  T Inaoka; G Bilbe; O Ishibashi; K Tezuka; M Kumegawa; T Kokubo
Journal:  Biochem Biophys Res Commun       Date:  1995-01-05       Impact factor: 3.575

10.  Human cathepsin O2, a matrix protein-degrading cysteine protease expressed in osteoclasts. Functional expression of human cathepsin O2 in Spodoptera frugiperda and characterization of the enzyme.

Authors:  D Brömme; K Okamoto; B B Wang; S Biroc
Journal:  J Biol Chem       Date:  1996-01-26       Impact factor: 5.157

View more
  65 in total

Review 1.  Notch and the regulation of osteoclast differentiation and function.

Authors:  Jungeun Yu; Ernesto Canalis
Journal:  Bone       Date:  2020-06-08       Impact factor: 4.398

2.  Macrophage cathepsin K promotes prostate tumor progression in bone.

Authors:  M K Herroon; E Rajagurubandara; D L Rudy; A Chalasani; A L Hardaway; I Podgorski
Journal:  Oncogene       Date:  2012-05-21       Impact factor: 9.867

3.  Rosmarinic acid and arbutin suppress osteoclast differentiation by inhibiting superoxide and NFATc1 downregulation in RAW 264.7 cells.

Authors:  Akina Omori; Yoshitaka Yoshimura; Yoshiaki Deyama; Kuniaki Suzuki
Journal:  Biomed Rep       Date:  2015-04-17

4.  Potential role of cathepsin K in the pathophysiology of mucopolysaccharidoses.

Authors:  Susan Wilson; Dieter Brömme
Journal:  J Pediatr Rehabil Med       Date:  2010

5.  Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss.

Authors:  X Yuan; J Cao; T Liu; Y-P Li; F Scannapieco; X He; M J Oursler; X Zhang; J Vacher; C Li; D Olson; S Yang
Journal:  Cell Death Differ       Date:  2015-04-24       Impact factor: 15.828

6.  Sophocarpine attenuates wear particle-induced implant loosening by inhibiting osteoclastogenesis and bone resorption via suppression of the NF-κB signalling pathway in a rat model.

Authors:  Chen-He Zhou; Zhong-Li Shi; Jia-Hong Meng; Bin Hu; Chen-Chen Zhao; Yu-Te Yang; Wei Yu; Ze-Xin Chen; Boon Chin Heng; Virginia-Jeni Akila Parkman; Shuai Jiang; Han-Xiao Zhu; Hao-Bo Wu; Wei-Liang Shen; Shi-Gui Yan
Journal:  Br J Pharmacol       Date:  2018-02-14       Impact factor: 8.739

7.  WSS25, a sulfated polysaccharide, inhibits RANKL-induced mouse osteoclast formation by blocking SMAD/ID1 signaling.

Authors:  Cheng Chen; Yi Qin; Jian-ping Fang; Xin-yan Ni; Jian Yao; Hai-ying Wang; Kan Ding
Journal:  Acta Pharmacol Sin       Date:  2015-08-24       Impact factor: 6.150

8.  The 1,2,3-triazole derivative KP-A021 suppresses osteoclast differentiation and function by inhibiting RANKL-mediated MEK-ERK signaling pathway.

Authors:  Hye Jung Ihn; Doohyun Lee; Taeho Lee; Hong-In Shin; Yong Chul Bae; Sang-Hyun Kim; Eui Kyun Park
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-13

9.  Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities.

Authors:  Susan Wilson; Saadat Hashamiyan; Lorne Clarke; Paul Saftig; John Mort; Valeria M Dejica; Dieter Brömme
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

10.  Ferulic acid impairs osteoclast fusion and exacerbates survival of mature osteoclasts.

Authors:  Travers Sagar; Mpho Rantlha; Marlena C Kruger; Magdalena Coetzee; Vishwa Deepak
Journal:  Cytotechnology       Date:  2016-07-23       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.